Global Drug Eluting Stents
Market Report
2024
Drug Eluting Stents Market Report 2024 (Global Edition)
As per Cognitive Market Research's latest published report, the Global Drug Eluting Stents market size was $2,897.2 million in 2022. Drug Eluting Stents Industry's Compound Annual Growth Rate will be 6.6 % from 2022 to 2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Drug Eluting Stents Market Report 2024.
Global Drug Eluting Stents Market Report 2024 Market Size Split by Type (Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Others), by Application (Coronary Artery Diseases, Peripheral Artery ...
As per Cognitive Market Research's latest published report, the Global Drug Eluting Stents market size was $2,897.2 million in 2022. Drug Eluting Stents Industry's Compound Annual Growth Rate will be 6.6 % from 2023 to 2030
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Drug Eluting Stents Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 6.6% |
| Market Split by Type |
|
| Market Split by Application |
|
| Market Split by Coating Type |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Drug Eluting Stents industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Drug Eluting Stents Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Drug Eluting Stents Market Report Description
What is a Drug Eluting stent?
Drug-eluting stent is a peripheral or coronary stent placed into narrowed, diseased peripheral, or coronary arteries that gradually release a drug to block cell proliferation. Drug-eluting stents are covered with medication, which is released to stop the growth of scar tissues in arterial walls. The eluted drug supports arteries to remain smooth and exposed, which confirms suitable blood flow and decreases the probability of restenosis. DES is observed as the gold standard for the treatment of coronary heart disease, as it provides various benefits such as enhanced vessel healing, minimally invasive nature, and reduced need for prolonged dual antiplatelet therapy.
What is Driving Drug Eluting Stents Industry Growth?
Growing unhealthy food habits, lack of exercise, and sedentary lifestyles increase the prevalence of atherosclerosis which boosts the demand for the global market. In addition, the rising geriatric population drives the growth of the drug-eluting stents market. Furthermore, the increasing prevalence of several cardiovascular diseases such as abnormal heart rhythms, heart attacks, and many others provides opportunities to the market players. However, strict government regulations for product approval may hamper the growth of the global market.
We have various report editions of Drug Eluting Stents Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Drug Eluting Stents Market Insights Video
Drug Eluting Stents Industry News:
In May 2022, Medtronic plc received United States Food and Drug Administration (FDA) approval for the Onyx Frontier drug-eluting stent (DES). Onyx Frontier DES, the newest member of the Resolute DES family, has the same best-in-class stent platform as Resolute OnyxTM DES and includes a new administration mechanism designed to improve acute performance in the most problematic individuals
Top Companies Market Share in Drug Eluting Stents Industry: (In no particular order of Rank)
- Abbott Vascular
- Advantec Vascular
- B.Braun Melsengen AG
- Biosensors
- Biotronik
- Blue Medical
- Boston Scientific
- DISA Vascular
- Essen
- Medtronic Vascular
- MicroPort Medical
- MIV Therapeutics
- Orbusneich
- Promed Medical
- Relisys Medical
- Reva Medical
- Sahajanand
- Sino Medical
- Sorin
- Terumo Medical
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America dominates the Drug-eluting Stents market with the highest revenue share!
North America dominates the drug-eluting stents market with the highest revenue share. This is attributed to the increasing geriatric population, the development of the R&D sector, and the rise in healthcare reforms, which are expected to drive the demand for the growth of the global market. Furthermore, Asia Pacific is anticipated to register the growth of the global market with the highest growth rate. increase in the prevalence of coronary artery disease and peripheral artery disease is anticipated to drive the demand for the global market in the country in the region.
The current report Scope analyzes Drug Eluting Stents Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Drug Eluting Stents Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Drug Eluting Stents Market Analysis
Global Drug Eluting Stents Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Drug Eluting Stents Industry growth. Drug Eluting Stents market has been segmented with the help of its Type, Application Coating Type, and others. Drug Eluting Stents market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
Drug Eluting Stents Market, by Drug Type
By drug type, the market is segmented into sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, and others. The Sirolimus segment is anticipated to drive the demand for the growth of the global market.
- Sirolimus
- Paclitaxel
- Zotarolimus
- Everolimus
- Biolimus
- Others
Drug Eluting Stents Market Share (%) by Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Drug Eluting Stents Industry. Request a Free Sample PDF!
Drug Eluting Stents Market: by Application
The coronary artery disease segment is anticipated to dominate the global market, due to the rise in the prevalence of coronary artery disease, and the increase in the adoption of drug-eluting stents.
- Coronary Artery Diseases
- Peripheral Artery Diseases
Drug Eluting Stents Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Drug Eluting Stents market report 2024 Edition by contacting our team.
Drug Eluting Stents Coating Type Segment Analysis
By coating type the market is segmented into a polymer-based coating, and polymer-free coatings. The polymer-free coating segment has the largest revenue share for the growth of the global market. This is attributed to the quicker drug eluting rate and higher drug loading capacity of nanoporous surfaces.
- Polymer-based Coatings
- Polymer-free Coatings
Drug Eluting Stents End User Segment Analysis
The market is segmented into Hospitals, Ambulatory Surgical Centers, Cardiology Centers, and Others. Hospitals accounted for the major revenue share for the growth of the global market. Rising healthcare expenditure and the development of new hospitals in emerging countries drive global market growth.
- Cardiology Centers
- Ambulatory Surgery Centers (ASCs)
- Hospitals
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Drug Eluting Stents Market is witnessing significant growth in the near future.
In 2023, the Sirolimus segment accounted for noticeable share of global Drug Eluting Stents Market and is projected to experience significant growth in the near future.
The Coronary Artery Diseases segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Vascular, B.Braun Melsengen AG and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Latest News about Drug Eluting Stents Market
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.export.gov
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Drug Eluting Stents Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Type | Sirolimus, Paclitaxel, Zotarolimus, Everolimus, Biolimus, Others |
| Application | Coronary Artery Diseases, Peripheral Artery Diseases |
| Coating Type | Polymer-based Coatings, Polymer-free Coatings |
| End User | Cardiology Centers, Ambulatory Surgery Centers (ASCs), Hospitals |
| List of Competitors | Abbott Vascular, Advantec Vascular, B.Braun Melsengen AG, Biosensors, Biotronik, Blue Medical, Boston Scientific, DISA Vascular, Essen, Medtronic Vascular, MicroPort Medical, MIV Therapeutics, Orbusneich, Promed Medical, Relisys Medical, Reva Medical, Sahajanand, Sino Medical, Sorin, Terumo Medical |
This chapter will help you gain GLOBAL Market Analysis of Drug Eluting Stents. Further deep in this chapter, you will be able to review Global Drug Eluting Stents Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Drug Eluting Stents Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Drug Eluting Stents Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Drug Eluting Stents Revenue Market Size By Region
-
-
1.3 Global Drug Eluting Stents Market Size By Type 2019 -2031
-
1.3.1 Sirolimus Market Size
-
1.3.2 Paclitaxel Market Size
-
1.3.3 Zotarolimus Market Size
-
1.3.4 Everolimus Market Size
-
1.3.5 Biolimus Market Size
-
1.3.6 Others Market Size
-
-
1.4 Global Drug Eluting Stents Market Size By Application 2019 -2031
-
1.4.1 Coronary Artery Diseases Market Size
-
1.4.2 Peripheral Artery Diseases Market Size
-
-
1.5 Global Drug Eluting Stents Market Size By Coating Type 2019 -2031
-
1.5.1 Polymer-based Coatings Market Size
-
1.5.2 Polymer-free Coatings Market Size
-
-
1.6 Global Drug Eluting Stents Market Size By End User for 2019 -2031
-
1.6.1 Cardiology Centers Market Size
-
1.6.2 Ambulatory Surgery Centers (ASCs) Market Size
-
1.6.3 Hospitals Market Size
-
-
1.7 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.8 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.8.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.8.2 Global Market Revenue Split By Type
-
1.8.3 Global Market Revenue Split By Application
-
1.8.4 Global Market Revenue Split By Coating Type
-
1.8.5 Global Market Revenue Split By End User
-
1.8.6 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Drug Eluting Stents Market Size 2019 - 2031
-
2.1.1 North America Drug Eluting Stents Market Size By Country 2019 - 2031
-
2.1.2 North America Drug Eluting Stents Market Size by Type 2019 -2031
-
2.1.2.1 North America Sirolimus Market Size
-
2.1.2.2 North America Paclitaxel Market Size
-
2.1.2.3 North America Zotarolimus Market Size
-
2.1.2.4 North America Everolimus Market Size
-
2.1.2.5 North America Biolimus Market Size
-
2.1.2.6 North America Others Market Size
-
-
2.1.3 North America Drug Eluting Stents Market Size by Application 2019 -2031
-
2.1.3.1 North America Coronary Artery Diseases Market Size
-
2.1.3.2 North America Peripheral Artery Diseases Market Size
-
-
2.1.4 North America Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
2.1.4.1 North America Polymer-based Coatings Market Size
-
2.1.4.2 North America Polymer-free Coatings Market Size
-
-
2.1.5 North America Drug Eluting Stents Market Size by End User 2019 -2031
-
2.1.5.1 North America Cardiology Centers Market Size
-
2.1.5.2 North America Ambulatory Surgery Centers (ASCs) Market Size
-
2.1.5.3 North America Hospitals Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America Drug Eluting Stents Market Trends North America Drug Eluting Stents Technological Road Map North America Drug Eluting Stents Market Drivers North America Drug Eluting Stents Market Restraints North America Drug Eluting Stents Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Type
-
2.3.3 North America Market Revenue Split By Application
-
2.3.4 North America Market Revenue Split By Coating Type
-
2.3.5 North America Market Revenue Split By End User
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Drug Eluting Stents Market Size 2019 - 2031
-
3.1.1 Europe Drug Eluting Stents Market Size By Country 2019 - 2031
-
3.1.2 Europe Drug Eluting Stents Market Size by Type 2019 -2031
-
3.1.2.1 Europe Sirolimus Market Size
-
3.1.2.2 Europe Paclitaxel Market Size
-
3.1.2.3 Europe Zotarolimus Market Size
-
3.1.2.4 Europe Everolimus Market Size
-
3.1.2.5 Europe Biolimus Market Size
-
3.1.2.6 Europe Others Market Size
-
-
3.1.3 Europe Drug Eluting Stents Market Size by Application 2019 -2031
-
3.1.3.1 Europe Coronary Artery Diseases Market Size
-
3.1.3.2 Europe Peripheral Artery Diseases Market Size
-
-
3.1.4 Europe Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
3.1.4.1 Europe Polymer-based Coatings Market Size
-
3.1.4.2 Europe Polymer-free Coatings Market Size
-
-
3.1.5 Europe Drug Eluting Stents Market Size by End User 2019 -2031
-
3.1.5.1 Europe Cardiology Centers Market Size
-
3.1.5.2 Europe Ambulatory Surgery Centers (ASCs) Market Size
-
3.1.5.3 Europe Hospitals Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Type
-
3.3.3 Europe Market Revenue Split By Application
-
3.3.4 Europe Market Revenue Split By Coating Type
-
3.3.5 Europe Market Revenue Split By End User
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific Drug Eluting Stents Market Size 2019 - 2031
-
4.1.1 Asia Pacific Drug Eluting Stents Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Drug Eluting Stents Market Size by Type 2019 -2031
-
4.1.2.1 Asia Pacific Sirolimus Market Size
-
4.1.2.2 Asia Pacific Paclitaxel Market Size
-
4.1.2.3 Asia Pacific Zotarolimus Market Size
-
4.1.2.4 Asia Pacific Everolimus Market Size
-
4.1.2.5 Asia Pacific Biolimus Market Size
-
4.1.2.6 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Drug Eluting Stents Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Coronary Artery Diseases Market Size
-
4.1.3.2 Asia Pacific Peripheral Artery Diseases Market Size
-
-
4.1.4 Asia Pacific Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
4.1.4.1 Asia Pacific Polymer-based Coatings Market Size
-
4.1.4.2 Asia Pacific Polymer-free Coatings Market Size
-
-
4.1.5 Asia Pacific Drug Eluting Stents Market Size by End User 2019 -2031
-
4.1.5.1 Asia Pacific Cardiology Centers Market Size
-
4.1.5.2 Asia Pacific Ambulatory Surgery Centers (ASCs) Market Size
-
4.1.5.3 Asia Pacific Hospitals Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Type
-
4.3.3 Asia Pacific Market Revenue Split By Application
-
4.3.4 Asia Pacific Market Revenue Split By Coating Type
-
4.3.5 Asia Pacific Market Revenue Split By End User
-
Chapter 5 South America Market Analysis
-
5.1 South America Drug Eluting Stents Market Size 2019 - 2031
-
5.1.1 South America Drug Eluting Stents Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America Drug Eluting Stents Market Size by Type 2019 -2031
-
5.1.2.1 South America Sirolimus Market Size
-
5.1.2.2 South America Paclitaxel Market Size
-
5.1.2.3 South America Zotarolimus Market Size
-
5.1.2.4 South America Everolimus Market Size
-
5.1.2.5 South America Biolimus Market Size
-
5.1.2.6 South America Others Market Size
-
-
5.1.3 South America Drug Eluting Stents Market Size by Application 2019 -2031
-
5.1.3.1 South America Coronary Artery Diseases Market Size
-
5.1.3.2 South America Peripheral Artery Diseases Market Size
-
-
5.1.4 South America Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
5.1.4.1 South America Polymer-based Coatings Market Size
-
5.1.4.2 South America Polymer-free Coatings Market Size
-
-
5.1.5 South America Drug Eluting Stents Market Size by End User 2019 -2031
-
5.1.5.1 South America Cardiology Centers Market Size
-
5.1.5.2 South America Ambulatory Surgery Centers (ASCs) Market Size
-
5.1.5.3 South America Hospitals Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Type
-
5.3.3 South America Market Revenue Split By Application
-
5.3.4 South America Market Revenue Split By Coating Type
-
5.3.5 South America Market Revenue Split By End User
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Drug Eluting Stents Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Drug Eluting Stents Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Drug Eluting Stents Market Size by Type 2019 -2031
-
6.1.2.1 Middle East and Africa Sirolimus Market Size
-
6.1.2.2 Middle East and Africa Paclitaxel Market Size
-
6.1.2.3 Middle East and Africa Zotarolimus Market Size
-
6.1.2.4 Middle East and Africa Everolimus Market Size
-
6.1.2.5 Middle East and Africa Biolimus Market Size
-
6.1.2.6 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa Drug Eluting Stents Market Size by Application 2019 -2031
-
6.1.3.1 Middle East and Africa Coronary Artery Diseases Market Size
-
6.1.3.2 Middle East and Africa Peripheral Artery Diseases Market Size
-
-
6.1.4 Middle East and Africa Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
6.1.4.1 Middle East and Africa Polymer-based Coatings Market Size
-
6.1.4.2 Middle East and Africa Polymer-free Coatings Market Size
-
-
6.1.5 Middle East and Africa Drug Eluting Stents Market Size by End User 2019 -2031
-
6.1.5.1 Middle East and Africa Cardiology Centers Market Size
-
6.1.5.2 Middle East and Africa Ambulatory Surgery Centers (ASCs) Market Size
-
6.1.5.3 Middle East and Africa Hospitals Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Type
-
6.3.3 Middle East and Africa Market Revenue Split By Application
-
6.3.4 Middle East and Africa Market Revenue Split By Coating Type
-
6.3.5 Middle East and Africa Market Revenue Split By End User
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Drug Eluting Stents Market Size by Type 2019 -2031
-
7.1.2 Country 1Drug Eluting Stents Market Size by Application 2019 -2031
-
7.1.3 Country 1Drug Eluting Stents Market Size by Coating Type 2019 -2031
-
7.1.4 Country 1Drug Eluting Stents Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Drug Eluting Stents Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott Vascular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Advantec Vascular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 B.Braun Melsengen AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Biosensors
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Biotronik
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Blue Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Boston Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 DISA Vascular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Essen
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Medtronic Vascular
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 MicroPort Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 MIV Therapeutics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Orbusneich
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 Promed Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Relisys Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Reva Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 Sahajanand
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Sino Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 Sorin
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
8.2.20 Terumo Medical
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.20.2 Business Overview
-
8.2.20.3 Financials (Subject to data availability)
-
8.2.20.4 Product Types Specification
-
8.2.20.5 Business Strategy
-
8.2.20.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2019 -2031
-
10.1 Sirolimus
-
10.1.1 Global Drug Eluting Stents Revenue Market Size and Share by Sirolimus 2019 -2031
-
-
10.2 Paclitaxel
-
10.2.1 Global Drug Eluting Stents Revenue Market Size and Share by Paclitaxel 2019 -2031
-
-
10.3 Zotarolimus
-
10.3.1 Global Drug Eluting Stents Revenue Market Size and Share by Zotarolimus 2019 -2031
-
-
10.4 Everolimus
-
10.4.1 Global Drug Eluting Stents Revenue Market Size and Share by Everolimus 2019 -2031
-
-
10.5 Biolimus
-
10.5.1 Global Drug Eluting Stents Revenue Market Size and Share by Biolimus 2019 -2031
-
-
10.6 Others
-
10.6.1 Global Drug Eluting Stents Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Coronary Artery Diseases
-
11.1.1 Global Drug Eluting Stents Revenue Market Size and Share by Coronary Artery Diseases 2019 - 2031
-
-
11.2 Peripheral Artery Diseases
-
11.2.1 Global Drug Eluting Stents Revenue Market Size and Share by Peripheral Artery Diseases 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Coating Type Analysis 2019 -2031
-
12.1 Polymer-based Coatings
-
12.1.1 Global Drug Eluting Stents Revenue Market Size and Share by Polymer-based Coatings 2019 -2031
-
-
12.2 Polymer-free Coatings
-
12.2.1 Global Drug Eluting Stents Revenue Market Size and Share by Polymer-free Coatings 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by End User Analysis 2019 -2031
-
13.1 Cardiology Centers
-
13.1.1 Global Drug Eluting Stents Revenue Market Size and Share by Cardiology Centers 2019 -2031
-
-
13.2 Ambulatory Surgery Centers (ASCs)
-
13.2.1 Global Drug Eluting Stents Revenue Market Size and Share by Ambulatory Surgery Centers (ASCs) 2019 -2031
-
-
13.3 Hospitals
-
13.3.1 Global Drug Eluting Stents Revenue Market Size and Share by Hospitals 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Drug Eluting Stents market
Chapter 14 Research Findings
-
14.1 Key Takeaways
-
14.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
14.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Drug Eluting Stents Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Drug Eluting Stents Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Drug Eluting Stents Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Drug Eluting Stents Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Drug Eluting Stents Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Drug Eluting Stents Market
Key Questions Answered By Drug Eluting Stents Market Report 2024
| Why Sirolimus have a significant impact on Drug Eluting Stents market? |
| What are the key factors affecting the Sirolimus and Paclitaxel of Drug Eluting Stents Market? |
| What is the CAGR/Growth Rate of Coronary Artery Diseases during the forecast period? |
| By type, which segment accounted for largest share of the global Drug Eluting Stents Market? |
| Which region is expected to dominate the global Drug Eluting Stents Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
